EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum markers for prognostic value of EGFR-TKI in lung adenocarcinoma with bone metastases: a retrospective study

Jiali Li, Shuting Wang, Zhiyong Deng, Lu Zhang, Min Liu, Yunlei Luo, Yunqiu Guo, Pengjie Liu, Chao Liu

PeerJ · 2026

DOI: 10.7717/peerj.20537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2026. Verfasst von Jiali Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Puer People's Hospital, Puer, Yunnan, China. Hauptthemen laut MEDLINE: Bone Neoplasms, Lung Neoplasms, Adenocarcinoma of Lung, Biomarkers, Tumor. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation, Regional Science Foundation Project, Joint Program of Applied Basic Research of Yunnan Provincial Department of Science and Technology-Kunming Medical University, “Famous Doctor” Special Project of Ten Thousand People Plan of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung adenocarcinoma is a prevalent malignancy. Mutations in the epidermal growth factor receptor (EGFR) have introduced novel prospects for targeted therapies. However, the status of EGFR mutations alone may be insufficient to fully predict treatment outcomes. To this end, the present research was performed to evaluate the serum markers associated with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment in patients with lung adenocarcinoma and bone metastases, specifically focusing on the prognostic value of EGFR-TKI therapy.

Methods

A retrospective analysis was conducted on 164 patients diagnosed with lung adenocarcinoma and bone metastases at Yunnan Cancer Hospital between January 2019 and December 2020. Clinical and follow-up data were collected, and a Cox regression model was employed to evaluate the combined predictive value of serum markers for survival outcomes.

Results

The findings revealed that variables identified through Cox regression analysis included age, the neutrophil-to-lymphocyte ratio (NLR), carcinoembryonic antigen (CEA), and Cytokeratin 19 fragment (Cyfra21-1), all exhibiting significance levels of P < 0.05. The Cox model exhibited a c-index of 0.644, and the calibration curve demonstrated satisfactory performance, indicating the moderate predictive capacity of the model. A nomogram was subsequently constructed to visualize these results.

Conclusion

This research successfully developed a nomogram based on the Cox regression model to predict prognosis and treatment outcomes in patients with lung adenocarcinoma and bone metastases undergoing EGFR-TKI therapy. This facilitates the avoidance of poor treatment outcomes by enabling individualized therapeutic approaches, thereby simplifying the development of the most appropriate treatment plans and ultimately improving patient prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsLung NeoplasmsAdenocarcinoma of LungBiomarkers, TumorProtein Kinase InhibitorsHumansRetrospective StudiesFemaleErbB ReceptorsMalePrognosisMiddle AgedAgedKeratin-19Carcinoembryonic AntigenNomogramsProportional Hazards Models

Stichwörter der Autor:innen

Bone metastasesEGFR-TKILung adenocarcinomPrognostic predictionSerum markers

Substanzen

ErbB ReceptorsBiomarkers, TumorProtein Kinase InhibitorsEGFR protein, humanKeratin-19Carcinoembryonic Antigen

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Puer People's Hospital, Puer, Yunnan, China.
  • Department of Nuclear Medicine, The Third Affiliated Hospital of Kunming Medical University, Kunming Medical College, Kunming, Yunnan, China.
  • Department of Thoracic Surgery,The Third Affiliated Hospital of Kunming Medical University, Kunming Medical College, Kunming, Yunnan, China.

Förderung

  • National Natural Science Foundation, Regional Science Foundation Project
  • Joint Program of Applied Basic Research of Yunnan Provincial Department of Science and Technology-Kunming Medical University
  • “Famous Doctor” Special Project of Ten Thousand People Plan of Yunnan Province
  • Yunnan Provincial Department of Education Science Research Fund Project
  • Medical Leading Talents Training Program of Yunnan Provincial Health Commission
  • Key Project of the Joint Special Program of Kunming Medical University

Zitieren

APA

Li, J., Wang, S., Deng, Z., Zhang, L., Liu, M., Luo, Y., Guo, Y., Liu, P., & Liu, C. (2026). Serum markers for prognostic value of EGFR-TKI in lung adenocarcinoma with bone metastases: a retrospective study. PeerJ. https://doi.org/10.7717/peerj.20537

Vancouver

Li J, Wang S, Deng Z, Zhang L, Liu M, Luo Y, et al. Serum markers for prognostic value of EGFR-TKI in lung adenocarcinoma with bone metastases: a retrospective study. PeerJ. 2026. doi:10.7717/peerj.20537

BibTeX
@article{Li2026,
  author = {Li, Jiali and Wang, Shuting and Deng, Zhiyong and Zhang, Lu and Liu, Min and Luo, Yunlei and Guo, Yunqiu and Liu, Pengjie and Liu, Chao},
  title = {Serum markers for prognostic value of EGFR-TKI in lung adenocarcinoma with bone metastases: a retrospective study},
  journal = {PeerJ},
  year = {2026},
  doi = {10.7717/peerj.20537}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche